Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Knowing Lichenoid Dermatoses: Common Pathways and Treatment
Description
The session focuses on lichenoid dermatoses, specifically detailing lichen planus, lichen planopilaris, and lichen planus pigmentosis. It highlights the exciting advancements in therapies that could significantly improve patient outcomes. The discussion features three key speakers: Dr. Crystal Agu from Johns Hopkins, Dr. Jeff Cohen from Yale, and Matt Besley, also from Yale. The speakers will cover various aspects of lichenoid dermatoses, starting with an overview of immunopathogenesis by Matt Besley, who will explain the similarities and differences among the subtypes. Dr. Cohen will emphasize the systemic nature of lichen planus and lichen planopilaris, underscoring the necessity for systemic treatment. Finally, Dr. Agu will delve into current and emerging therapies for the conditions. The session will conclude with a panel discussion where attendees can ask questions of the experts.
Conclusions
- Lichenoid dermatoses, including lichen planus, lichen planopilaris, and lichen planus pigmentosis, are significant conditions that require attention due to their systemic nature.
- The study emphasizes that lichen planus and lichen planopilaris are systemic diseases, potentially necessitating systemic therapy.
- Emerging therapies for lichenoid dermatoses have the potential to greatly improve patient outcomes and quality of life.
- Understanding the immunopathogenesis of lichenoid dermatoses can reveal both common pathways and distinctions among different subtypes.
- The presentations aim to highlight current knowledge and future directions in the treatment of lichenoid dermatoses.